Literature DB >> 19049545

Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease.

N Souayah1, R L Chin, T H Brannagan, N Latov, P H R Green, A Kokoszka, H W Sander.   

Abstract

BACKGROUND: Cerebellar syndrome and small fiber neuropathy may complicate celiac disease (CD) and may be resistant to a strict gluten-free diet.
METHODS: Case series.
RESULTS: We report three patients with biopsy-proven CD who developed cerebellar ataxia and neuropathic pain despite strict adherence to a gluten-free diet. A small fiber neuropathy was suggested by skin biopsy findings in two patients. All patients' symptoms, including small fiber neuropathy symptoms, responded to treatment with intravenous immunoglobulin (IVIG). Discontinuation of IVIG in two patients resulted in worsened ataxia that reversed after resumption of IVIG.
CONCLUSION: Intravenous immunoglobulin may be effective in treating cerebellar ataxia and small fiber neuropathy associated with CD, suggesting an immune pathogenesis. Further prospective, controlled studies are necessary to determine the long-term response to IVIG or other immunomodulation therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049545     DOI: 10.1111/j.1468-1331.2008.02305.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

Review 1.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

2.  Celiac sprue: a unique autoimmune disorder.

Authors:  Shadi Rashtak; Eric V Marietta; Joseph A Murray
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

3.  Downbeat nystagmus, ataxia and spastic tetraparesis due to coeliac disease.

Authors:  Mario Habek; Iva Hojsak; Barbara Barun; Vesna V Brinar
Journal:  Neurol Sci       Date:  2011-03-10       Impact factor: 3.307

4.  Anti transglutaminase antibodies cause ataxia in mice.

Authors:  Sabrina Boscolo; Andrea Lorenzon; Daniele Sblattero; Fiorella Florian; Marco Stebel; Roberto Marzari; Tarcisio Not; Daniel Aeschlimann; Alessandro Ventura; Marios Hadjivassiliou; Enrico Tongiorgi
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

5.  Gluten ataxia in Japan.

Authors:  Kazunori Nanri; Hiroshi Mitoma; Masafumi Ihara; Nobuyuki Tanaka; Takeshi Taguchi; Masafumi Takeguchi; Tomoko Ishiko; Hidehiro Mizusawa
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

Review 6.  [Neurological complications of inflammatory bowel diseases].

Authors:  N Cieplik; M Stangel; O Bachmann
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 7.  Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies.

Authors:  Anne Louise Oaklander
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

8.  Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.

Authors:  Margot Geerts; Bianca T A de Greef; Maurice Sopacua; Sander M J van Kuijk; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Neurology       Date:  2021-03-25       Impact factor: 9.910

Review 9.  The clinical approach to small fibre neuropathy and painful channelopathy.

Authors:  Andreas C Themistocleous; Juan D Ramirez; Jordi Serra; David L H Bennett
Journal:  Pract Neurol       Date:  2014-04-28

Review 10.  Guidelines for treatment of immune-mediated cerebellar ataxias.

Authors:  Hiroshi Mitoma; Marios Hadjivassiliou; Jérôme Honnorat
Journal:  Cerebellum Ataxias       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.